AZGP1 and neoplasm: By comparing AZGP1 expression between Met and non-Met subgroups, we further confirmed our findings that tumor cells with lower AZGP1 expression exhibited metastatic capability (P = 2.289 × 10–7; Supplementary Fig. 1).